IP Library Granted Patent US 9,427,360
Granted Patent B2
US 9,427,360 · App. 13/289,453 · Granted Aug 30, 2016

Hemostatic fabric

Inventor: W. Jerry Mezger (Coto de Caza, CA)
A61F13/00008A61F13/00034A61F2013/00463A61F2013/00472
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,427,360
App. No.
13/289,453
Granted
Aug 30, 2016
Kind
B2
Abstract

Disclosed herein are hemostatic fabrics that include agents, including metal fibers or powders, that can control bleeding and contribute to faster wound healing.

Claims (20)

1. A hemostatic fabric consisting of:

at least one selected from the group consisting of: a metal thread, a metal powder, and a combination thereof configured to stimulate the formation of a blood clot; and

a secondary fabric consisting of at least one of natural or synthetic fibers to support and accelerate hemostasis.

2. The hemostatic fabric of claim 1 , wherein the metal thread, metal powder, or combination thereof comprises steel.

3. The hemostatic fabric of claim 1 , wherein the metal thread, metal powder, or combination thereof comprises tungsten.

4. The hemostatic fabric of claim 1 , wherein the metal thread, metal powder, or combination thereof comprises titanium.

5. The hemostatic fabric of claim 1 , wherein the metal thread, metal powder, or combination thereof comprises platinum.

6. The hemostatic fabric of claim 1 , wherein the metal thread, metal powder, or combination thereof comprises silver.

7. The hemostatic fabric of claim 1 , wherein the metal thread, metal powder, or combination thereof comprises tantalum.

8. The hemostatic fabric of claim 1 , wherein the metal thread, metal powder, or combination thereof comprises palladium.

9. The hemostatic fabric of claim 1 , wherein the metal thread, metal powder, or combination thereof comprises a metallic alloy.

10. The hemostatic fabric of claim 1 , wherein the secondary fabric comprises antimicrobial properties to reduce or control infectious agents.

11. A method of achieving hemostasis in a patient, comprising:

providing a hemostatic fabric consisting of at least one selected from the group consisting of: a metal thread, a metal powder, and a combination thereof; and a secondary fabric consisting of at least one of natural or synthetic fibers to reduce the adherence of the hemostatic fabric to the wound;

identifying a site of the patient where there is bleeding; and

stimulating formation of a blood clot, wherein stimulating formation of a blood clot comprises positioning the hemostatic fabric at the site of bleeding.

12. A hemostatic fabric, consisting of:

at least one selected from the group consisting of: a metal thread, a metal powder, and a combination thereof configured to stimulate the formation of a blood clot; and

a secondary fabric comprising at least one of natural or synthetic fibers to reduce the adherence of the hemostatic fabric to the wound,

wherein the secondary fabric does not comprise any additional hemostatic materials.

Assignments (2)
RELEASE OF SECURITY INTEREST Recorded Apr 12, 2021
From: KNOBBE, MARTENS, OLSON & BEAR, LLP
To: MEZGER, WILLIAM JERRY
Reel/Frame 056235/0035 →
SECURITY INTEREST Recorded Dec 18, 2018
From: MEZGER, WILLIAM JERRY
To: KNOBBE, MARTENS, OLSON & BEAR, LLP
Reel/Frame 048680/0983 →
Continuity (2)
Provisional Application 61410191 · Nov 4, 2010
Related Publication 20120116280A1 · May 10, 2012